ZSAN Zosano Pharma Corporation gains 73% Mar 23, 2018

Posted By: Rajesh Srivastava - Friday, March 23, 2018

Share

& Comment

Zosano Pharma Corporation, a clinical stage pharmaceutical company, develops a proprietary intracutaneous delivery system to administer drugs through the skin for rapid symptom relief to patients. Its lead product candidate is M207, a proprietary formulation of zolmitriptan used for the treatment of migraine. The company was founded in 2006 and is headquartered in Fremont, California. http://www.priceseries.com/trade/ZSAN-Zosano-Pharma-Corporation-stock-gains-73-percent-a-Trade-Record-by-priceSeries-2018030620180323.html

About Rajesh Srivastava

Techism is an online Publication that complies Bizarre, Odd, Strange, Out of box facts about the stuff going around in the world which you may find hard to believe and understand. The Main Purpose of this site is to bring reality with a taste of entertainment

0 comments:

Post a Comment

Subscribe to: Post Comments (Atom)

Copyright © priceSeries Daily Results™ is a registered trademark.

Designed by Templateism. Hosted on Blogger Platform.